Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · Real-Time Price · USD

2.330

-0.020 (-0.85%)

At close: Jun 27, 2025, 4:00 PM

2.560

+0.230 (9.87%)

After-hours: Jun 27, 2025, 7:56 PM EDT

Galectin Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Galectin Therapeutics stock has a target of 6.00, which predicts a 157.51% increase from the current stock price of 2.33.

Price Target: $6.00 (+157.51%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6.00	$6.00	$6.00	$6.00
Change	+157.51%	+157.51%	+157.51%	+157.51%

Analyst Ratings

The average analyst rating for Galectin Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	0	0	0	0	0	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+157.51%	Jun 17, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 2, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Dec 27, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $11	Strong Buy	Reiterates	$11	+372.10%	Nov 15, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $11	Strong Buy	Reiterates	$11	+372.10%	Aug 16, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.91

from -0.76

EPS Next Year

-1.13

from -0.91

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	37.05M	183.28M	392.95M	583.66M
Revenue Growth	-	394.74%	114.40%	48.53%	-	-	-	-
EPS	-0.41	-0.52	-0.65	-0.74	-0.76	-0.91	-1.13	-0.65
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	38.1M	188.7M	404.5M
Avg	37.0M	183.3M	393.0M
Low	35.6M	176.1M	377.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	409.3%	120.7%
Avg	-	394.7%	114.4%
Low	-	375.4%	106.0%

EPS Forecast

EPS	2025	2026	2027
High	-0.93	-1.17	-0.67
Avg	-0.91	-1.13	-0.65
Low	-0.87	-1.09	-0.63

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.